J

Jazz Pharmaceuticals

Biopharmaceuticals focused on neuroscience and oncology

Senior Manager - Real World Evidence

Clinical Research OperationsUpdated on Nov 13
Full-time$151.2k - $226.8kRemote

About the Job

Requirements

  • At least 6 years of research project management experience in biotechnology, pharmaceuticals, or contract research organizations.
  • At least 3 years of experience leading observational studies, covering prospective designs such as registries and cohorts and retrospective designs such as electronic health record or claims database studies, chart reviews, and secondary data analyses.
  • Deep operational understanding of real-world data sources, including Flatiron, Optum, IQVIA, Datavant linkages, claims databases, and registries.
  • Knowledge of non-interventional study governance, ethics committee or IRB waiver processes, informed consent for observational cohorts, and health data privacy regulations including HIPAA and GDPR.
  • Familiarity with Good Pharmacoepidemiology Practice and ISPOR/ISPE guidelines for real-world evidence execution.
  • Proven experience managing multi-site prospective observational studies and complex retrospective secondary data projects.
  • Strong contract, budget, and vendor oversight experience with real-world evidence vendors, contract research organizations, and data platform providers.
  • Proficiency with electronic systems used in observational research, such as eTMF, CTMS, EDC, and data governance platforms.
  • Bachelor’s degree in Life Sciences, Epidemiology, Public Health, Health Informatics, Healthcare Administration, or a related field.

Responsibilities

  • Lead end-to-end operational planning, implementation, management, and closeout of global and regional observational studies across prospective and retrospective designs.
  • Drive operational execution of prospective observational cohorts, disease registries, pragmatic studies, retrospective chart reviews, and secondary real-world data linkage projects.
  • Facilitate and lead cross-functional study team meetings, including Study Execution Teams, aligning real-world evidence leads, health economics and outcomes research, Medical Affairs, Biostatistics, Data Analytics, Regulatory, and Legal/Privacy.
  • Serve as the primary escalation point for study operational risks, data access hurdles, and timeline deviations, and drive proactive resolution.
  • Manage study-level documentation, including study master files, master protocol versions, operational plans, and data management plans, and ensure archiving in compliance with company standard operating procedures.
  • Lead cross-functional development and review of study-specific operational plans, protocol synopses, observational research protocols, statistical analysis plans, and feasibility assessments.
  • For prospective observational studies, oversee informed consent form templates, patient recruitment strategies, site selection, electronic case report form design, and site contracting.
  • For retrospective studies, oversee data abstraction form design, electronic health record and claims database licensing, data transfer specifications, data linkage agreements, and variable mapping documents.
  • Manage protocol amendments and IRB/Ethics Committee submission packages, supporting waiver of authorization applications for retrospective chart extractions or secondary data use.
  • Coordinate review and approval of final Study Reports and manuscripts with publication and scientific communications teams.
  • Manage operational performance of external service providers, including specialized real-world evidence contract research organizations, data aggregators, academic research institutions, and chart abstraction vendors.
  • Participate in vendor selection, Request for Proposal processes, scope of work drafting, and contract negotiations.
  • Manage and track study timelines and budgets against projected spend; analyze vendor financial invoicing, milestones, and change orders.
  • Monitor vendor deliverables and key performance indicators to ensure data quality, regulatory compliance, and protocol adherence.
  • Identify, assess, and proactively manage operational and data-related risks to protect study quality, data privacy, and delivery timelines.
  • Ensure observational research complies with Good Pharmacoepidemiology Practice, Good Clinical Practice where applicable, relevant local and international regulations, HIPAA/GDPR privacy rules, and internal standard operating procedures.
  • Act as the study operational lead and subject matter expert during internal audits, quality reviews, and regulatory inspections related to observational data generation.
  • Support program-level governance discussions with project status, milestone tracking, risk mitigation strategies, and budget updates for senior leadership.
  • Lead cross-functional Study Execution Teams and matrix teams to maintain performance and accountability.
  • Mentor and coach junior study managers, research associates, or project coordinators.
  • Drive operational process improvements, template updates, and standard operating procedure refinements within the Real-World Evidence/Evidence Operations organization.

Desired Qualifications

  • An advanced degree (Master’s or Ph.D.) in Epidemiology, Public Health, Health Economics, or Life Sciences.
  • Excellent organizational, time-management, and analytical skills.
  • Strong cross-functional leadership, stakeholder management, and written and verbal communication skills.
  • Ability to work effectively in matrixed environments across scientific, analytical, regulatory, and business units.

About the Company

Jazz Pharmaceuticals

Biopharmaceuticals focused on neuroscience and oncology

Jazz Pharmaceuticals is a global biopharmaceutical company focused on neuroscience and oncology, developing and selling therapies for diseases with limited options. Its portfolio includes Xyrem/Xywav for narcolepsy, Epidiolex for seizures, Zepzelca for small cell lung cancer, and Vyxeos for AML. The company grows through a mix of in-house R&D and strategic acquisitions (like GW Pharmaceuticals, Celator, Chimerix) to expand its pipeline. Its goal is to broaden approved therapies and reach patients with limited options by building a diversified, specialty-focused portfolio.

Company size
1,001-5,000
Company stage
IPO
Headquarters
Dublin, Ireland
Founded
2003

Recently Posted Jobs

Explore more opportunities at Jazz Pharmaceuticals

See more jobs